T0	Limitation 24366 24370	This
T1	Limitation 24527 24535	Although
T2	Limitation 24804 24806	In
T3	Limitation 25023 25031	Finally,
T4	Limitation 25373 25381	However,
T5	Intervention 24485 24525	nor did it quantify plaque lipid content
T7	RelevantOutcomeExcluded 24635 24652	no direct measure
T8	Control 24819 24893	no attempt was made to select subjects on the basis of inflammatory status
T11	NonstandardTreatmentCharacteristics 25071 25114	the dose of canakinumab was not high enough
T10	RelevantOutcomeExcluded 24366 24436	This study did not evaluate atherosclerosis at the carotid bifurcation
T12	Generalization 25382 25454	this small study cannot thoroughly or systematically evaluate the safety
